Lamberto Andreotti

Lamberto Andreotti (born 6 July 1950) is an Italian businessman. He is currently executive chairman of the board of Bristol Myers Squibb.[1]

Lamberto Andreotti
Born (1950-07-06) 6 July 1950
Rome, Italy
Alma materSapienza University of Rome (BS)
Massachusetts Institute of Technology (MS)
OccupationBusiness executive
Board member of
Parents

Biography

Early life

Andreotti was born in Rome, Italy, in 1950, the son of Italian Senator and President of the Council of Ministers Giulio Andreotti. He graduated from Sapienza University of Rome with a degree in engineering; he then earned a Master of Science degree from Massachusetts Institute of Technology.[2][3][4]

Professional roles

He worked for many pharmaceutical companies, including Farmitalia-Carlo Erba then with Pharmacia after Pharmacia acquired Farmitalia.[2]

In 1998, he joined Bristol-Myers Squibb as vice president and general manager of European Oncology and Italy.[2] He was elected to the Board of Directors in March 2009 and became CEO on 4 May 2010.[2] Prior to taking the role of CEO, he held the role of president and COO.[1] He retired from Bristol-Myers Squibb in 2015 and took on the role of executive chairman of the company's board, succeeding James M. Cornelius who was retiring from this role.[1]

He was elected to the board of DuPont in 2012.[5]

He was elected to the Board of Directors of UniCredit S.p.A. Bank on 12 May 2018.

References
  1. Staff (February 15, 2015). "BMS CEO Andreotti to Retire; COO Named as Successor". Genetic Engineering & Biotechnology News (paper). Vol. 35, no. 4. p. 6.
  2. "Bristol-Myers Squibb: Lamberto Andreotti". bms.com. May 2010. Retrieved June 12, 2012.
  3. Forbes
  4. "Lamberto Andreotti: Executive Profile & Biography - Businessweek". investing.businessweek.com. Archived from the original on January 18, 2013. Retrieved June 12, 2012.
  5. "Bio Lamberto Andreotti, CEO, Bristol-Myers Squibb". www2.dupont.com. April 2012. Retrieved June 12, 2012.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.